Listing 1 - 10 of 16 | << page >> |
Sort by
|
Choose an application
H4 R is the newest member of the histamine receptor family, which was discovered about twelve years ago. It is considered a very promising drug target. The effort to improve the pharmacokinetic properties of the currently available H4 R ligands is reflected in a steadily growing number of scientific publications and patent applications. Preclinical data strongly confirms the need for novel potent H4 R ligands to explore their therapeutic value in allergy, inflammation, autoimmune disorders, and possibly, cancer. Readers will be provided with extensive knowledge on histamine metabolism, as well as cellular histamine transport, storage and release, effects of histamine and histamine receptor ligands, with particular attention to the H4 R, on inflammatory cells including mast cells, basophils, eosinophils, neutrophils, macrophages, dendritic cells, and T cells. The present knowledge on the regulatory role of histamine and the therapeutic exploitation of histamine receptor ligands in atopic diseases, with emphasis on human and animal models of asthma, allergic dermatitis and pruritus are discussed.
Choose an application
H4 R is the newest member of the histamine receptor family, which was discovered about twelve years ago. It is considered a very promising drug target. The effort to improve the pharmacokinetic properties of the currently available H4 R ligands is reflected in a steadily growing number of scientific publications and patent applications. Preclinical data strongly confirms the need for novel potent H4 R ligands to explore their therapeutic value in allergy, inflammation, autoimmune disorders, and possibly, cancer. Readers will be provided with extensive knowledge on histamine metabolism, as well as cellular histamine transport, storage and release, effects of histamine and histamine receptor ligands, with particular attention to the H4 R, on inflammatory cells including mast cells, basophils, eosinophils, neutrophils, macrophages, dendritic cells, and T cells. The present knowledge on the regulatory role of histamine and the therapeutic exploitation of histamine receptor ligands in atopic diseases, with emphasis on human and animal models of asthma, allergic dermatitis and pruritus are discussed.
Choose an application
H4 R is the newest member of the histamine receptor family, which was discovered about twelve years ago. It is considered a very promising drug target. The effort to improve the pharmacokinetic properties of the currently available H4 R ligands is reflected in a steadily growing number of scientific publications and patent applications. Preclinical data strongly confirms the need for novel potent H4 R ligands to explore their therapeutic value in allergy, inflammation, autoimmune disorders, and possibly, cancer. Readers will be provided with extensive knowledge on histamine metabolism, as well as cellular histamine transport, storage and release, effects of histamine and histamine receptor ligands, with particular attention to the H4 R, on inflammatory cells including mast cells, basophils, eosinophils, neutrophils, macrophages, dendritic cells, and T cells. The present knowledge on the regulatory role of histamine and the therapeutic exploitation of histamine receptor ligands in atopic diseases, with emphasis on human and animal models of asthma, allergic dermatitis and pruritus are discussed.
Choose an application
Reproductive toxicology is a complex subject dealing with three components-parent, placenta, and fetus-and the continuous changes that occur in each. Reproductive and Developmental Toxicology is a comprehensive and authoritative resource providing the latest literature enriched with relevant references describing every aspect of this area of science. It addresses a broad range of topics including nanoparticles and radiation, gases and solvents, smoking, alcohol and drugs of abuse, food additives, nutraceuticals and pharmaceuticals, and metals, among others. With a special focus on placental toxicity, this book is the only available reference to connect the three key risk stages, and is the only resource to include reproductive and developmental toxicity in domestic animals, fish, and wildlife.
Congenital Abnormalities - embryology. --- Developmental toxicology. --- Embryonic Development - drug effects. --- Fetal Development - drug effects. --- Reproductive toxicology. --- Teratogens - toxicity. --- Toxicity Tests. --- Reproductive toxicology --- Toxicity Tests --- Embryonic Development --- Teratogens --- Toxicology & Public Health --- Toxicologie de la reproduction --- Toxicology, Developmental --- Toxicology --- Developmental biology --- Teratogenesis --- Congenital Abnormalities --- Fetal Development --- toxicity. --- embryology. --- drug effects.
Choose an application
Drugs --- Drug development. --- Parenteral solutions --- Standards. --- Quality control. --- Drug Development. --- Drug Development --- standards. --- Solutions, Parenteral --- Parenteral therapy --- Solutions (Pharmacy) --- Development of drugs --- New drug development --- Pharmacology --- Pharmacy --- Development --- Control, Quality --- Controls, Quality --- Quality Controls --- Scientific Experimental Error --- Total Quality Management --- Medication Development --- Pharmaceutical Development --- Computational Prediction of Drug-Target Interactions --- Drug Target Prediction --- Development, Drug --- Development, Medication --- Development, Pharmaceutical --- Drug Target Predictions --- Prediction, Drug Target --- Target Prediction, Drug --- Quality Control.
Choose an application
Pharmaceutical industry --- Drug development. --- Quality control. --- Drug Development. --- Efficiency, Organizational. --- Total Quality Management. --- Development of drugs --- Drugs --- New drug development --- Pharmacology --- Pharmacy --- Development --- Lean Six Sigma --- Sigma Metrics --- Six Sigma --- Continuous Quality Management --- Lean Six Sigmas --- Management, Continuous Quality --- Management, Total Quality --- Metric, Sigma --- Metrics, Sigma --- Sigma Metric --- Sigma, Six --- Sigmas, Six --- Six Sigma, Lean --- Six Sigmas --- Six Sigmas, Lean --- Quality Control --- Administrative Efficiency --- Organizational Productivity --- Efficiency, Administrative --- Productivity, Organizational --- Program Efficiency --- Efficiency, Program --- Organizational Efficiency --- Program Efficiencies --- Medication Development --- Pharmaceutical Development --- Computational Prediction of Drug-Target Interactions --- Drug Target Prediction --- Development, Drug --- Development, Medication --- Development, Pharmaceutical --- Drug Target Predictions --- Prediction, Drug Target --- Target Prediction, Drug
Choose an application
Drug development. --- Drug resistance in microorganisms. --- Drug Development --- Drug Resistance, Microbial --- Antimicrobial Drug Resistance --- Antibiotic Resistance --- Antibiotic Resistance, Microbial --- Antimicrobial Drug Resistances --- Drug Resistances, Microbial --- Resistance, Antibiotic --- Microbial Sensitivity Tests --- Medication Development --- Pharmaceutical Development --- Computational Prediction of Drug-Target Interactions --- Drug Target Prediction --- Development, Drug --- Development, Medication --- Development, Pharmaceutical --- Drug Target Predictions --- Prediction, Drug Target --- Target Prediction, Drug --- Antibiotic resistance in microorganisms --- Antibiotics resistance in microorganisms --- Bacterial resistance to antibiotics --- Drug resistance in micro-organisms --- Microbial drug resistance --- Resistance to drugs in microorganisms --- Microorganisms --- Development of drugs --- Drugs --- New drug development --- Pharmacology --- Pharmacy --- Effect of drugs on --- Development --- Drug Resistance, Microbial.
Choose an application
"The development of a robust drug product requires juggling many competing priorities such as overcoming scientific challenges, following regulatory requirements, and managing business-related concerns. Unfortunately, despite large resources spent on R&D, multifactor productivity of pharmaceuticals is on the decline for several years now. Because of this business reality, pharmaceutical companies have seen a notable change in the traditional operating model and footprint over the past couple of decades. Outsourcing, in particular, has emerged as a successful business model for many pharmaceutical companies looking for ways to strategically increase their R&D capabilities and to augment their in-house resources. How to Integrate Quality by Efficient Design (QbED) in Product Development bridges the gap between theory and practice when it comes to strategic decision-making in a pharmaceutical research scenario. This book will introduce the concept of QbED and focus on various aspects such as patient-centric product designs, platform-based manufacturing technologies, business acuity, and regulatory strategies to balance the challenges in outsourcing with the need for strategic and statistically sound experiments rooted in good science. Detailed discussions will cover pharmaceutical business models, regulatory approval process, quality by design (QbD), business analytics, and manufacturing excellence specifically for small molecules and solid oral dosage forms. With the addition of case studies, flowcharts, diagrams, and data visualizations, How to Integrate Quality by Efficient Design (QbED) in Product Development will be a practical reference to help professionals working in the area of pharmaceutical drug development, strategy, and outsourcing management"--
Ethics and addiction --- Pharmaceutical industry --- Drug development. --- Drug Development. --- Efficiency, Organizational. --- Total Quality Management. --- Quality control. --- Lean Six Sigma --- Sigma Metrics --- Six Sigma --- Continuous Quality Management --- Lean Six Sigmas --- Management, Continuous Quality --- Management, Total Quality --- Metric, Sigma --- Metrics, Sigma --- Sigma Metric --- Sigma, Six --- Sigmas, Six --- Six Sigma, Lean --- Six Sigmas --- Six Sigmas, Lean --- Quality Control --- Administrative Efficiency --- Organizational Productivity --- Efficiency, Administrative --- Productivity, Organizational --- Program Efficiency --- Efficiency, Program --- Organizational Efficiency --- Program Efficiencies --- Medication Development --- Pharmaceutical Development --- Computational Prediction of Drug-Target Interactions --- Drug Target Prediction --- Development, Drug --- Development, Medication --- Development, Pharmaceutical --- Drug Target Predictions --- Prediction, Drug Target --- Target Prediction, Drug --- Development of drugs --- Drugs --- New drug development --- Pharmacology --- Pharmacy --- Development
Choose an application
Pharmaceutical Biotechnology in Drug Development summarizes key concepts and the latest developments of biotechnology applied to the development of biopharmaceuticals. Chapters present a comprehensive collection of introductory biotechnology technologies and their modern concepts and cover pharmacokinetic and pharmacodynamic behavior of biopharmaceuticals and modification techniques of amino acids and nucleic acid. Other sections focus on topics such as gene therapy, immunological preparations and nanoparticles which are the major contributions of pharmaceutical biotechnology. Final chapters discuss emerging techniques in the field of pharmaceutical biotechnology to meet current patient and health care demand. This book is an essential reference useful for pharmaceutical scientists, clinicians and academic researchers who want easy access to up-to-date practices of pharmaceutical biotechnology. Corporate researchers will also benefit from this book’s succinct and objective content structure.
Drug Development. --- Nanoparticle Drug Delivery System. --- NDDSs --- Nano Delivery System --- Nano Drug Delivery Systems --- Nano-Drug Delivery System --- Nanoparticle Based Drug Delivery System --- Delivery System, Nano --- Delivery System, Nano-Drug --- Delivery Systems, Nano --- Delivery Systems, Nano-Drug --- Nano Delivery Systems --- Nano Drug Delivery System --- System, Nano Delivery --- System, Nano-Drug Delivery --- Systems, Nano Delivery --- Systems, Nano-Drug Delivery --- Medication Development --- Pharmaceutical Development --- Computational Prediction of Drug-Target Interactions --- Drug Target Prediction --- Development, Drug --- Development, Medication --- Development, Pharmaceutical --- Drug Target Predictions --- Prediction, Drug Target --- Target Prediction, Drug --- Pharmaceutical biotechnology. --- Drug development. --- Biological Products --- Biotechnology --- methods --- Biological Products. --- methods.
Choose an application
drug discovery --- drug delivery --- medicinal chemistry --- drug development and commercialization --- translational science --- cell therapy --- Pharmacy --- Drug development --- Drugs --- Drug development. --- Drug Discovery. --- Drug Development. --- Research --- Design --- Testing --- Design. --- Testing. --- Research. --- Medication Development --- Pharmaceutical Development --- Computational Prediction of Drug-Target Interactions --- Drug Target Prediction --- Development, Drug --- Development, Medication --- Development, Pharmaceutical --- Drug Target Predictions --- Prediction, Drug Target --- Target Prediction, Drug --- Drug Prospecting --- Discovery, Drug --- Prospecting, Drug --- High-Throughput Screening Assays --- Bioprospecting --- Clinical drug trials --- Clinical trials of drugs --- Drug bioscreening --- Drug trials --- Clinical pharmacology --- Drug design --- Pharmaceutical design --- Development of drugs --- New drug development --- Pharmacology --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Chemistry --- Medicine --- Clinical trials --- Effectiveness --- Evaluation --- Development --- Drug Discovery --- Drug Development
Listing 1 - 10 of 16 | << page >> |
Sort by
|